Oritavancin: a long-acting antibacterial lipoglycopeptide.

about

Treatment of Staphylococcus aureus Infections.

P2860

Q40049973-43C2AA7B-80FA-445C-A47F-D1183A906663

P2860

Oritavancin: a long-acting antibacterial lipoglycopeptide.

Item

http://www.wikidata.org/entity/Q38830176

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Oritavancin: a long-acting antibacterial lipoglycopeptide.

@en

type

Item

label

Oritavancin: a long-acting antibacterial lipoglycopeptide.

@en

prefLabel

Oritavancin: a long-acting antibacterial lipoglycopeptide.

@en

P1476

Oritavancin: a long-acting antibacterial lipoglycopeptide.

@en

P2093

Achim J Kaasch

http://www.w3.org/2001/XMLSchema#string

Harald Seifert

http://www.w3.org/2001/XMLSchema#string

P2860

Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing

Dalbavancin for the treatment of acute bacterial skin and skin structure infections

FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials.

Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study

Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trials.

Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.

Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis

Trends in US hospital admissions for skin and soft tissue infections

In vitro characterization of oritavancin clearance from human blood by low-flux, high-flux, and continuous renal replacement therapy dialyzers.

Oritavancin: mechanism of action.

P304

843-855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB-2016-0003

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27161039

http://www.w3.org/2001/XMLSchema#string

Oritavancin: a long-acting antibacterial lipoglycopeptide.

about

P2860

P2860

Oritavancin: a long-acting antibacterial lipoglycopeptide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698